Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Wyszukujesz frazę ""Syndrome"" wg kryterium: Temat


Starter badań:

Tytuł:
Gut microbiota composition is altered in postural orthostatic tachycardia syndrome and post-acute COVID-19 syndrome.
Autorzy:
Hamrefors V; Department of Clinical Sciences, Lund University, Malmö, Sweden. .; Department of Cardiology, Skåne University Hospital, Malmö, Sweden. .
Kahn F; Department of Infection Medicine, Skåne University Hospital, Malmö, Sweden.; Department of Clinical Sciences, Lund University, Lund, Sweden.
Holmqvist M; Department of Infection Medicine, Skåne University Hospital, Malmö, Sweden.; Department of Clinical Sciences, Lund University, Lund, Sweden.
Carlson K; Department of Infection Medicine, Skåne University Hospital, Malmö, Sweden.; Department of Clinical Sciences, Lund University, Lund, Sweden.
Varjus R; Clinical Microbiomics, Symbion, Copenhagen, Denmark.
Gudjonsson A; Clinical Microbiomics, Symbion, Copenhagen, Denmark.
Fedorowski A; Department of Cardiology, Karolinska University Hospital, Stockholm, Sweden.; Department of Medicine, Karolinska Institute, Stockholm, Sweden.
Ohlsson B; Department of Clinical Sciences, Lund University, Malmö, Sweden.; Department of Internal Medicine, Skåne University Hospital, Malmö, Sweden.
Pokaż więcej
Źródło:
Scientific reports [Sci Rep] 2024 Feb 09; Vol. 14 (1), pp. 3389. Date of Electronic Publication: 2024 Feb 09.
Typ publikacji:
Journal Article
MeSH Terms:
Postural Orthostatic Tachycardia Syndrome*/diagnosis
Irritable Bowel Syndrome*/complications
Gastrointestinal Microbiome*
COVID-19*/complications
Humans ; Post-Acute COVID-19 Syndrome
Czasopismo naukowe
Tytuł:
IA-PACS-CFS: a double-blinded, randomized, sham-controlled, exploratory trial of immunoadsorption in patients with chronic fatigue syndrome (CFS) including patients with post-acute COVID-19 CFS (PACS-CFS).
Autorzy:
Preßler H; Department of Neurology and Experimental Neurology, Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin and Berlin Institute of Health, Charitéplatz 1, Berlin, 10117, Germany.; Excellence Cluster NeuroCure, Berlin, Germany.
Machule ML; Department of Neurology and Experimental Neurology, Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin and Berlin Institute of Health, Charitéplatz 1, Berlin, 10117, Germany.; German Center for Neurodegenerative Diseases (DZNE) Berlin, Berlin, Germany.
Ufer F; Department of Neurology and Experimental Neurology, Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin and Berlin Institute of Health, Charitéplatz 1, Berlin, 10117, Germany.; German Center for Neurodegenerative Diseases (DZNE) Berlin, Berlin, Germany.
Bünger I; Department of Neurology and Experimental Neurology, Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin and Berlin Institute of Health, Charitéplatz 1, Berlin, 10117, Germany.; German Center for Neurodegenerative Diseases (DZNE) Berlin, Berlin, Germany.
Li LY; Department of Neurology and Experimental Neurology, Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin and Berlin Institute of Health, Charitéplatz 1, Berlin, 10117, Germany.; German Center for Neurodegenerative Diseases (DZNE) Berlin, Berlin, Germany.
Buchholz E; Department of Neurology and Experimental Neurology, Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin and Berlin Institute of Health, Charitéplatz 1, Berlin, 10117, Germany.; German Center for Neurodegenerative Diseases (DZNE) Berlin, Berlin, Germany.
Werner C; Clinical Research Organisation GmbH, Charitéplatz 1, Berlin, 10117, Germany.
Beraha E; Clinical Research Organisation GmbH, Charitéplatz 1, Berlin, 10117, Germany.
Wagner F; Clinical Research Organisation GmbH, Charitéplatz 1, Berlin, 10117, Germany.
Metz M; Department of Biostatistics, GCP-Service International Ltd. & Co. KG, Bremen, Germany.
Burock S; Clinical Trial Office, Charité - Universitätsmedizin Berlin, Charitéplatz 1, Berlin, 10117, Germany.
Bruckert L; Clinical Trial Office, Charité - Universitätsmedizin Berlin, Charitéplatz 1, Berlin, 10117, Germany.
Franke C; Department of Neurology and Experimental Neurology, Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin and Berlin Institute of Health, Charitéplatz 1, Berlin, 10117, Germany.; German Center for Neurodegenerative Diseases (DZNE) Berlin, Berlin, Germany.
Wilck N; Department of Nephrology and Medical Intensive Care Medicine, Charité-Universitätsmedizin Berlin, Berlin, Germany.; Experimental and Clinical Research Center (ECRC), a cooperation of Charité - Universitätsmedizin Berlin and Max Delbruck Center for Molecular Medicine (MDC), Berlin, 13125, Germany.; Max Delbrück Center for Molecular Medicine in the Helmholtz Association (MDC), Berlin, 13125, Germany.
Krüger A; Department of Nephrology and Medical Intensive Care Medicine, Charité-Universitätsmedizin Berlin, Berlin, Germany.
Reshetnik A; Department of Nephrology and Medical Intensive Care Medicine, Charité-Universitätsmedizin Berlin, Berlin, Germany.
Eckardt KU; Department of Nephrology and Medical Intensive Care Medicine, Charité-Universitätsmedizin Berlin, Berlin, Germany.; Department of Nephrology and Hypertension, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Germany.
Endres M; Department of Neurology and Experimental Neurology, Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin and Berlin Institute of Health, Charitéplatz 1, Berlin, 10117, Germany.; Excellence Cluster NeuroCure, Berlin, Germany.; German Center for Neurodegenerative Diseases (DZNE) Berlin, Berlin, Germany.; Center for Stroke Research Berlin, Charité-Universitätsmedizin Berlin, Berlin, Germany.
Prüss H; Department of Neurology and Experimental Neurology, Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin and Berlin Institute of Health, Charitéplatz 1, Berlin, 10117, Germany. .; German Center for Neurodegenerative Diseases (DZNE) Berlin, Berlin, Germany. .
Pokaż więcej
Źródło:
Trials [Trials] 2024 Mar 07; Vol. 25 (1), pp. 172. Date of Electronic Publication: 2024 Mar 07.
Typ publikacji:
Randomized Controlled Trial; Journal Article
MeSH Terms:
COVID-19*/therapy
Fatigue Syndrome, Chronic*/diagnosis
Fatigue Syndrome, Chronic*/therapy
Humans ; Post-Acute COVID-19 Syndrome ; SARS-CoV-2 ; Pandemics ; Canada
Czasopismo naukowe
Tytuł:
Association of circulating biomarkers with illness severity measures differentiates myalgic encephalomyelitis/chronic fatigue syndrome and post-COVID-19 condition: a prospective pilot cohort study.
Autorzy:
Domingo JC; Department of Biochemistry and Molecular Biomedicine, Faculty of Biology, University of Barcelona, Barcelona, 08028, Spain.
Battistini F; Molecular Modelling and Bioinformatics Group, Institute for Research in Biomedicine, Barcelona Institute of Science and Technology, Barcelona, 08028, Spain.
Cordobilla B; Department of Biochemistry and Molecular Biomedicine, Faculty of Biology, University of Barcelona, Barcelona, 08028, Spain.
Zaragozá MC; Clinical Research Department, Laboratorios Viñas, Barcelona, 08012, Spain.
Sanmartin-Sentañes R; Division of Rheumatology, Clinical Unit in ME/CFS and Long COVID, Vall d'Hebron University Hospital, Universitat Autònoma de Barcelona, Barcelona, 08035, Spain.; Division of Rheumatology, Research Unit in ME/CFS and Long COVID, Vall d'Hebron Research Institute, Universitat Autònoma de Barcelona, Barcelona, 08035, Spain.
Alegre-Martin J; Division of Rheumatology, Clinical Unit in ME/CFS and Long COVID, Vall d'Hebron University Hospital, Universitat Autònoma de Barcelona, Barcelona, 08035, Spain.; Division of Rheumatology, Research Unit in ME/CFS and Long COVID, Vall d'Hebron Research Institute, Universitat Autònoma de Barcelona, Barcelona, 08035, Spain.
Cambras T; Department of Biochemistry and Physiology, Faculty of Pharmacy and Food Sciences, University of Barcelona, Barcelona, 08028, Spain. .
Castro-Marrero J; Division of Rheumatology, Research Unit in ME/CFS and Long COVID, Vall d'Hebron Research Institute, Universitat Autònoma de Barcelona, Barcelona, 08035, Spain. .
Pokaż więcej
Źródło:
Journal of translational medicine [J Transl Med] 2024 Apr 10; Vol. 22 (1), pp. 343. Date of Electronic Publication: 2024 Apr 10.
Typ publikacji:
Journal Article
MeSH Terms:
Fatigue Syndrome, Chronic*/epidemiology
COVID-19*
Humans ; Post-Acute COVID-19 Syndrome ; Cross-Sectional Studies ; Pilot Projects ; Prospective Studies ; Cohort Studies ; Patient Acuity ; Biomarkers ; Inflammation
Czasopismo naukowe
Tytuł:
Systemic inflammatory response syndrome in patients with severe fever with thrombocytopenia syndrome: prevalence, characteristics, and impact on prognosis.
Autorzy:
Zhang Z; Department of Infectious Disease, Zhongnan Hospital of Wuhan University, Wuhan, China.
Hu X; Department of Infectious Diseases, Tongji Hospital, Tongji Medical College and State Key Laboratory for Diagnosis and Treatment of Severe Zoonotic Infectious Disease, Huazhong University of Science and Technology, Wuhan, China.
Jiang Q; Department of Infectious Disease, Zhongnan Hospital of Wuhan University, Wuhan, China.
Jiao F; Department of Infectious Disease, Zhongnan Hospital of Wuhan University, Wuhan, China.
Du Q; Department of Infectious Disease, Zhongnan Hospital of Wuhan University, Wuhan, China.
Liu J; Department of Infectious Disease, Zhongnan Hospital of Wuhan University, Wuhan, China.
Luo M; Department of Infectious Disease, Zhongnan Hospital of Wuhan University, Wuhan, China.
Li A; Department of Clinical Laboratory, Center for Gene Diagnosis, and Program of Clinical Laboratory Medicine, Zhongnan Hospital of Wuhan University, Wuhan, China. .
Deng L; Department of Infectious Disease, Zhongnan Hospital of Wuhan University, Wuhan, China. .
Xiong Y; Department of Infectious Disease, Zhongnan Hospital of Wuhan University, Wuhan, China. .
Pokaż więcej
Źródło:
BMC infectious diseases [BMC Infect Dis] 2024 Jan 30; Vol. 24 (1), pp. 149. Date of Electronic Publication: 2024 Jan 30.
Typ publikacji:
Journal Article
MeSH Terms:
Severe Fever with Thrombocytopenia Syndrome*
Phlebovirus*
Thrombocytopenia*/complications
Humans ; Retrospective Studies ; Prevalence ; Fever/epidemiology ; Prognosis ; Systemic Inflammatory Response Syndrome/epidemiology ; Systemic Inflammatory Response Syndrome/complications ; China/epidemiology
Czasopismo naukowe
Tytuł:
Mitochondrial Dysfunction and Coenzyme Q10 Supplementation in Post-Viral Fatigue Syndrome: An Overview.
Autorzy:
Mantle D; Pharma Nord (UK) Ltd., Morpeth, Northumberland NE61 2DB, UK.
Hargreaves IP; School of Pharmacy and Biomolecular Sciences, Liverpool John Moores University, Liverpool L3 3AF, UK.
Domingo JC; Department of Biochemistry and Molecular Biomedicine, Faculty of Biology, University of Barcelona, 08028 Barcelona, Spain.
Castro-Marrero J; Research Unit in ME/CFS and Long COVID, Rheumatology Division, Vall d'Hebron Research Institute, Universitat Autònoma de Barcelona, 08035 Barcelona, Spain.
Pokaż więcej
Źródło:
International journal of molecular sciences [Int J Mol Sci] 2024 Jan 01; Vol. 25 (1). Date of Electronic Publication: 2024 Jan 01.
Typ publikacji:
Journal Article; Review
MeSH Terms:
Fatigue Syndrome, Chronic*/drug therapy
Fatigue Syndrome, Chronic*/etiology
Fibromyalgia*/drug therapy
Fibromyalgia*/etiology
Mitochondrial Diseases*
Ubiquinone/*analogs & derivatives
Humans ; Post-Acute COVID-19 Syndrome ; Myalgia ; Dietary Supplements
Czasopismo naukowe
Tytuł:
Dysautonomia and small fiber neuropathy in post-COVID condition and Chronic Fatigue Syndrome.
Autorzy:
Azcue N; Neurodegenerative Diseases Group, Biocruces Bizkaia Health Research Institute, Plaza de Cruces 12, 48903, Barakaldo (Bizkaia), CP, Spain.
Del Pino R; Neurodegenerative Diseases Group, Biocruces Bizkaia Health Research Institute, Plaza de Cruces 12, 48903, Barakaldo (Bizkaia), CP, Spain. .
Acera M; Neurodegenerative Diseases Group, Biocruces Bizkaia Health Research Institute, Plaza de Cruces 12, 48903, Barakaldo (Bizkaia), CP, Spain.
Fernández-Valle T; Neurodegenerative Diseases Group, Biocruces Bizkaia Health Research Institute, Plaza de Cruces 12, 48903, Barakaldo (Bizkaia), CP, Spain.; Department of Neurology, Cruces University Hospital-OSAKIDETZA, Barakaldo, Spain.; Department of Neurosciences, University of the Basque Country UPV/EHU, Leioa, Spain.
Ayo-Mentxakatorre N; Neurodegenerative Diseases Group, Biocruces Bizkaia Health Research Institute, Plaza de Cruces 12, 48903, Barakaldo (Bizkaia), CP, Spain.
Pérez-Concha T; Department of Neurology, Cruces University Hospital-OSAKIDETZA, Barakaldo, Spain.; Department of Medicine, School of Medicine, University of Deusto, Bilbao, Spain.
Murueta-Goyena A; Neurodegenerative Diseases Group, Biocruces Bizkaia Health Research Institute, Plaza de Cruces 12, 48903, Barakaldo (Bizkaia), CP, Spain.; Department of Neurosciences, University of the Basque Country UPV/EHU, Leioa, Spain.
Lafuente JV; Department of Neurosciences, University of the Basque Country UPV/EHU, Leioa, Spain.
Prada A; Department of Immunology, Donostia University Hospital-OSAKIDETZA, San Sebastián, Spain.; Spanish Network for the Research in Multiple Sclerosis, San Sebastian, Spain.
López de Munain A; Department of Neurology, Donostia University Hospital-OSAKIDETZA, San Sebastián, Spain.; Department of Neurosciences, Biodonostia Health Research Institute, San Sebastián, Spain.; Department of Neurosciences, University of the Basque Country UPV-EHU, San Sebastián, Spain.; Department of Medicine, School of Medicine, University of Deusto, Bilbao, Spain.; CIBERNED-CIBER, Institute Carlos III, Madrid, Spain.
Ruiz Irastorza G; Autoimmune Diseases Research Unit, Biocruces Bizkaia Health Research Institute, Barakaldo, Spain.; Department of Autoimmune Diseases, Cruces University Hospital-OSAKIDETZA, Barakaldo, Spain.
Martín-Iglesias D; Autoimmune Diseases Research Unit, Biocruces Bizkaia Health Research Institute, Barakaldo, Spain.; Department of Autoimmune Diseases, Cruces University Hospital-OSAKIDETZA, Barakaldo, Spain.
Ribacoba L; Department of Internal Medicine, Cruces University Hospital, Barakaldo, Spain.
Gabilondo I; Neurodegenerative Diseases Group, Biocruces Bizkaia Health Research Institute, Plaza de Cruces 12, 48903, Barakaldo (Bizkaia), CP, Spain.; Department of Neurology, Cruces University Hospital-OSAKIDETZA, Barakaldo, Spain.; The Basque Foundation for Science, IKERBASQUE, Bilbao, Spain.
Gómez-Esteban JC; Neurodegenerative Diseases Group, Biocruces Bizkaia Health Research Institute, Plaza de Cruces 12, 48903, Barakaldo (Bizkaia), CP, Spain. .; Department of Neurology, Cruces University Hospital-OSAKIDETZA, Barakaldo, Spain. .; Department of Neurosciences, University of the Basque Country UPV/EHU, Leioa, Spain. .; Department of Medicine, School of Medicine, University of Deusto, Bilbao, Spain. .; CIBERNED-CIBER, Institute Carlos III, Madrid, Spain. .
Tijero-Merino B; Neurodegenerative Diseases Group, Biocruces Bizkaia Health Research Institute, Plaza de Cruces 12, 48903, Barakaldo (Bizkaia), CP, Spain.; Department of Neurology, Cruces University Hospital-OSAKIDETZA, Barakaldo, Spain.; Department of Medicine, School of Medicine, University of Deusto, Bilbao, Spain.; CIBERNED-CIBER, Institute Carlos III, Madrid, Spain.
Pokaż więcej
Źródło:
Journal of translational medicine [J Transl Med] 2023 Nov 15; Vol. 21 (1), pp. 814. Date of Electronic Publication: 2023 Nov 15.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Fatigue Syndrome, Chronic*/diagnosis
Small Fiber Neuropathy*
COVID-19*/complications
Postural Orthostatic Tachycardia Syndrome*/diagnosis
Humans ; Post-Acute COVID-19 Syndrome
Czasopismo naukowe
Tytuł:
Inflammatory and Prothrombotic Biomarkers Contribute to the Persistence of Sequelae in Recovered COVID-19 Patients.
Autorzy:
Garcia-Larragoiti N; División de Estudios de Posgrado, Facultad de Ciencias Médicas y Biológicas 'Dr. Ignacio Chávez', Universidad Michoacana de San Nicolás de Hidalgo, Morelia 58060, Michoacán, Mexico.
Cano-Mendez A; División de Estudios de Posgrado, Facultad de Ciencias Médicas y Biológicas 'Dr. Ignacio Chávez', Universidad Michoacana de San Nicolás de Hidalgo, Morelia 58060, Michoacán, Mexico.; Centro Multidisciplinario de Estudios en Biotecnología, Facultad de Medicina Veterinaria y Zootecnia, Universidad Michoacana de San Nicolás de Hidalgo, Morelia 58060, Michoacán, Mexico.
Jimenez-Vega Y; División de Estudios de Posgrado, Facultad de Ciencias Médicas y Biológicas 'Dr. Ignacio Chávez', Universidad Michoacana de San Nicolás de Hidalgo, Morelia 58060, Michoacán, Mexico.
Trujillo M; División de Estudios de Posgrado, Facultad de Ciencias Médicas y Biológicas 'Dr. Ignacio Chávez', Universidad Michoacana de San Nicolás de Hidalgo, Morelia 58060, Michoacán, Mexico.
Guzman-Cancino P; División de Estudios de Posgrado, Facultad de Ciencias Médicas y Biológicas 'Dr. Ignacio Chávez', Universidad Michoacana de San Nicolás de Hidalgo, Morelia 58060, Michoacán, Mexico.
Ambriz-Murillo Y; División de Estudios de Posgrado, Facultad de Ciencias Médicas y Biológicas 'Dr. Ignacio Chávez', Universidad Michoacana de San Nicolás de Hidalgo, Morelia 58060, Michoacán, Mexico.; Hospital Regional de Morelia ISSSTE, Morelia 58300, Michoacán, Mexico.
Viveros-Sandoval ME; División de Estudios de Posgrado, Facultad de Ciencias Médicas y Biológicas 'Dr. Ignacio Chávez', Universidad Michoacana de San Nicolás de Hidalgo, Morelia 58060, Michoacán, Mexico.
Pokaż więcej
Źródło:
International journal of molecular sciences [Int J Mol Sci] 2023 Dec 14; Vol. 24 (24). Date of Electronic Publication: 2023 Dec 14.
Typ publikacji:
Journal Article
MeSH Terms:
COVID-19*/complications
Metabolic Syndrome*
Humans ; von Willebrand Factor/metabolism ; Post-Acute COVID-19 Syndrome ; Quality of Life ; SARS-CoV-2/metabolism ; Biomarkers ; Disease Progression
Czasopismo naukowe
Tytuł:
Genetic risk factors for severe and fatigue dominant long COVID and commonalities with ME/CFS identified by combinatorial analysis.
Autorzy:
Taylor K; PrecisionLife Ltd, Unit 8B Bankside, Hanborough Business Park, Oxford, OX29 8LJ, UK.
Pearson M; PrecisionLife Ltd, Unit 8B Bankside, Hanborough Business Park, Oxford, OX29 8LJ, UK.
Das S; PrecisionLife Ltd, Unit 8B Bankside, Hanborough Business Park, Oxford, OX29 8LJ, UK.
Sardell J; PrecisionLife Ltd, Unit 8B Bankside, Hanborough Business Park, Oxford, OX29 8LJ, UK.
Chocian K; PrecisionLife Ltd, Unit 8B Bankside, Hanborough Business Park, Oxford, OX29 8LJ, UK.
Gardner S; PrecisionLife Ltd, Unit 8B Bankside, Hanborough Business Park, Oxford, OX29 8LJ, UK. .
Pokaż więcej
Źródło:
Journal of translational medicine [J Transl Med] 2023 Nov 01; Vol. 21 (1), pp. 775. Date of Electronic Publication: 2023 Nov 01.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Fatigue Syndrome, Chronic*/diagnosis
COVID-19*/complications
COVID-19*/genetics
Humans ; Post-Acute COVID-19 Syndrome ; SARS-CoV-2 ; Risk Factors
Czasopismo naukowe
Tytuł:
"When," "Where," and "How" of SARS-CoV-2 Infection Affects the Human Cardiovascular System: A Narrative Review.
Autorzy:
Kounis NG; Department of Cardiology, University of Patras Medical School, Rio, Greece.
Gogos C; Clinic of Cardiology, COVID-19 Unit, Papageorgiou General Hospital, Pavlos Melas, Greece.
de Gregorio C; Department of Clinical and Experimental Medicine, University of Messina Medical School, Messina, Italy.
Hung MY; Division of Cardiology, Department of Internal Medicine, Shuang Ho Hospital, Taipei Medical University, Taipei, Taiwan.
Kounis SN; Speech Therapy Practice, Rio, Greece.
Tsounis EP; Division of Gastroenterology, Department of Internal Medicine, Medical School, University Hospital of Patras, Rio, Greece.
Assimakopoulos SF; Department of Internal Medicine, Division of Infectious Diseases, University of Patras Medical School, Rio, Greece.
Pourmasumi S; Social Determinants of Health Research Center, Rafsanjan University of Medical Sciences, Rafsanjan, Iran.
Mplani V; Intensive Care Unit, Patras University Hospital, Rio, Greece.
Servos G; Pediatric Cardiology Unit, 'P. & A. Kyriakou' Children's Hospital, Athina, Greece.
Dousdampanis P; Department of Nephrology, Saint Andrews State General Hospital, Patras, Greece.
Plotas P; Department of Cardiology, University of Patras Medical School, Rio, Greece.
Michalaki MA; Department of Internal Medicine, Division of Endocrinology, University of Patras, School of Health Sciences, Rio, Greece.
Tsigkas G; Department of Cardiology, University of Patras Medical School, Rio, Greece.
Grammatikopoulos G; Private Practice Neuroncenter, Neuron Neurology Center, Rio, Greece.
Velissaris D; Department of Internal Medicine, University of Patras Medical School, Rio, Greece.
Koniar I; Electrophysiology and Device Department, University Hospital of South Manchester NHS Foundation Trust, Manchester, United Kingdom.
Pokaż więcej
Źródło:
Balkan medical journal [Balkan Med J] 2024 Jan 03; Vol. 41 (1), pp. 7-22.
Typ publikacji:
Review; Journal Article
MeSH Terms:
COVID-19*/complications
Kounis Syndrome*
Cardiovascular System*/metabolism
Child ; Humans ; SARS-CoV-2/metabolism ; Renin-Angiotensin System/physiology ; Angiotensin-Converting Enzyme 2/metabolism ; Peptidyl-Dipeptidase A/metabolism ; Cytokine Release Syndrome/etiology ; Endothelial Cells/metabolism ; Pandemics
Czasopismo naukowe
Tytuł:
Sclerosing epithelioid fibrosarcoma associated with WRN gene variant presenting as chronic dyspnea and pathologic cervical fracture: a case report and review of the literature.
Autorzy:
Phan AT; Department of Internal Medicine, Arrowhead Regional Medical Center, 400 N. Pepper Avenue, Colton, CA, 92324, USA. .; California University of Science and Medicine, Colton, CA, 92324, USA. .
Ghantarchyan H; Department of Internal Medicine, Arrowhead Regional Medical Center, 400 N. Pepper Avenue, Colton, CA, 92324, USA.; California University of Science and Medicine, Colton, CA, 92324, USA.
Khosravi C; Department of Pulmonary and Critical Care Medicine, Arrowhead Regional Medical Center, Colton, CA, 92324, USA.; California University of Science and Medicine, Colton, CA, 92324, USA.
Maknouni B; Department of Pulmonary and Critical Care Medicine, Arrowhead Regional Medical Center, Colton, CA, 92324, USA.; California University of Science and Medicine, Colton, CA, 92324, USA.
Bhagat A; Department of Internal Medicine, Arrowhead Regional Medical Center, 400 N. Pepper Avenue, Colton, CA, 92324, USA.; California University of Science and Medicine, Colton, CA, 92324, USA.
Chen J; California University of Science and Medicine, Colton, CA, 92324, USA.
Ibrahim A; Department of Pathology, Arrowhead Regional Medical Center, Colton, CA, 92324, USA.
Hasan M; Department of Pulmonary and Critical Care Medicine, Arrowhead Regional Medical Center, Colton, CA, 92324, USA.; California University of Science and Medicine, Colton, CA, 92324, USA.
Pokaż więcej
Źródło:
Journal of medical case reports [J Med Case Rep] 2023 Dec 17; Vol. 17 (1), pp. 517. Date of Electronic Publication: 2023 Dec 17.
Typ publikacji:
Review; Case Reports; Journal Article
MeSH Terms:
Werner Syndrome*
Fibrosarcoma*/complications
Fibrosarcoma*/diagnosis
Fibrosarcoma*/genetics
Sarcoma*
Fractures, Spontaneous*
Spinal Fractures*
Neck Injuries*
Middle Aged ; Humans ; Female ; Adult ; Tomography, X-Ray Computed ; Dyspnea ; Werner Syndrome Helicase
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies